Synovo GmbH

Synovo GmbH is an SME in Tuebingen, Germany that has taken part in 11 EU-funded projects since 2008, receiving €4.4M in EU funding and leading 1 as coordinator.

EU funding received€4.4M
EU projects11
As coordinator1
Running now1
First EU project2008
Latest project2024
CountryGermany
EU registration (PIC)999545231
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Synovo GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€3.0M · 7 projects
  • Horizon 2020€902k · 3 projects
  • Horizon Europe€559k · 1 project

Projects

11 EU-funded projects, newest first. Synovo GmbH led 1 of them as coordinator. Each links to the official record.

  • EvaMobsPartner

    Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €559ktheir share
  • Algae4IBDPartner

    ALGAE4IBD –FROM NATURE TO BEDSIDE- ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMATION, PAIN AND IBD

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €58ktheir share
  • NOVIRUSES2BRAINPartner

    ''One size fits all'' unique drug to eradicate multiple viral species simultaneously from the central nervous system of co-infected individuals

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

    €548ktheir share
  • FOLSMARTPartner

    Folate-Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €296ktheir share
  • InFactPartner

    Functional materials for fast diagnosis of wound infection

    FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗

    €489ktheir share
  • TIMCCPartner

    Tumor Infiltrating Myeloid Cell Compartment

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €191ktheir share
  • VISIONPartner

    Prolonged inhibition of semaphorine3a pathway via a bio-degradable implant towards a better therapy for visual sensory impairments

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €1.2Mtheir share
  • NOVOPartner

    Novel approaches for prevention and degeneration of pathogenic bacteria biofilms formed on medical devices e.g. catheters

    FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗

    €317ktheir share
  • NANOFOLPartner

    Folate-based nanobiodevices for integrated diagnosis/therapy targeting chronic inflammatory diseases

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €368ktheir share
  • PEP2BRAINPartner

    Selected peptides as drug candidates directed to pain and neurodegeneration

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €124ktheir share
  • KINACEPTCoordinator

    Novel anti-inflammatory compounds for autoimmune diseases

    FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗

    €301ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • antibiotics
  • arteriosclerosis
  • autoimmune diseases
  • biomolecules
  • coating and films
  • colors
  • coronaviruses
  • drug discovery
  • enzymes
  • functional analysis
  • genetic engineering
  • genetics
  • glaucoma

Synovo GmbH is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime